The present investigation aimed at assessing the impact of serum albumin levels on long-term outcomes in a cohort of aspirin-treated T2DM subjects without overt cardiovascular disease, showing hypoalbuminemia to be associated with an enhanced risk of cardiovascular events. Here, ALB is linked to cardiovascular disorder.